FOSFORMENNCT07932158
Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible Enterobacteria
StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Clinical cure
Timeframe: At day 26
Secondary (6)
Cumulative incidence of infectious and urological complications
Adherence to treatment
Occurence of adverse events related to anticiotics
Rectal carriage of phenotypically antibiotic-resistant Enterobacterales
Rates of recurrence of febrile or non-febrile UTIs (relapse or reinfection)
Show 1 moreShow less
Number of patients who experienced treatment failure
Arms and interventions
Fosfomycin-trometamol (FT)Experimental
Reference treatments as per the French SPLIF guidlinesActive comparator
Drugs: Fosfomycin-trometamol, Reference treatments